APDERM MANAGEMENT, LLC – Trademark Portfolio

Entity Type: 16

APDERM MANAGEMENT, LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 5 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include APDERM and MEDI TRESSE. The owner is based in ACTON, MA.

526 MAIN STREET, STE 302

ACTON, MA 01720

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

APDERM MANAGEMENT, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (5 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does APDERM MANAGEMENT, LLC have?

APDERM MANAGEMENT, LLC has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.

What trademark classes does APDERM MANAGEMENT, LLC file in?

APDERM MANAGEMENT, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are APDERM MANAGEMENT, LLC's most well-known trademarks?

APDERM MANAGEMENT, LLC's registered trademark portfolio includes well-known marks such as APDERM and MEDI TRESSE. These are among 5 currently registered trademarks in the portfolio.

What is APDERM MANAGEMENT, LLC's trademark registration success rate?

APDERM MANAGEMENT, LLC has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.